Chemoinformaics analysis of CYCLOHEX-3-EN-1-OL
Molecular Weight | 98.145 | nRot | 0 |
Heavy Atom Molecular Weight | 88.065 | nRig | 16 |
Exact Molecular Weight | 98.0732 | nRing | 1 |
Solubility: LogS | -4.508 | nHRing | 0 |
Solubility: LogP | 4.448 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 17 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 17.4899 |
nHD | 1 | BPOL | 10.0321 |
QED | 0.458 |
Synth | 3.089 |
Natural Product Likeliness | 1.712 |
NR-PPAR-gamma | 0.01 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.983 |
Pgp-sub | 0.006 |
HIA | 0.003 |
CACO-2 | -4.69 |
MDCK | 0.0000215 |
BBB | 0.027 |
PPB | 0.934687 |
VDSS | 1.5 |
FU | 0.0415724 |
CYP1A2-inh | 0.891 |
CYP1A2-sub | 0.811 |
CYP2c19-inh | 0.607 |
CYP2c19-sub | 0.256 |
CYP2c9-inh | 0.525 |
CYP2c9-sub | 0.851 |
CYP2d6-inh | 0.429 |
CYP2d6-sub | 0.879 |
CYP3a4-inh | 0.219 |
CYP3a4-sub | 0.382 |
CL | 11.236 |
T12 | 0.129 |
hERG | 0.074 |
Ames | 0.11 |
ROA | 0.203 |
SkinSen | 0.147 |
Carcinogencity | 0.899 |
EI | 0.201 |
Respiratory | 0.251 |
NR-Aromatase | 0.402 |
Antiviral | No |
Prediction | 0.950276 |